The first patient has been dosed in exPDite-2, a registrational Phase 3 clinical trial testing the safety and efficacy of bemdaneprocel, an investigational stem cell therapy that Bluerock Therapeutics is […] The post First patient dosed in Phase 3 trial of bemdaneprocel for Parkinson’s appeared first on Parkinson's News Today.
